Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
0(0%)
Results Posted
27%(3 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_2
2
13%
Ph phase_1
8
53%
Ph phase_4
2
13%
Ph phase_3
3
20%

Phase Distribution

8

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
8(53.3%)
Phase 2Efficacy & side effects
2(13.3%)
Phase 3Large-scale testing
3(20.0%)
Phase 4Post-market surveillance
2(13.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Completed(11)
Terminated(1)
Other(3)

Detailed Status

Completed11
unknown3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Phase 18 (53.3%)
Phase 22 (13.3%)
Phase 33 (20.0%)
Phase 42 (13.3%)

Trials by Status

terminated17%
unknown320%
completed1173%

Recent Activity

0 active trials
Showing 5 of 15
completedphase_1

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

NCT00093353
completedphase_2

Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae

NCT05294588
completedphase_4

The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial)

NCT04349826
completedphase_4

Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea

NCT06090565
unknownphase_3

Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract

NCT02021006
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT00093353Phase 1

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

Completed
NCT05294588Phase 2

Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae

Completed
NCT04349826Phase 4

The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial)

Completed
NCT06090565Phase 4

Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea

Completed
NCT02021006Phase 3

Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract

Unknown
NCT02596503Phase 1

A Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors

Completed
NCT03840811Phase 1

Experimental Human Infection With Neisseria Gonorrhoeae

Completed
NCT00786669Phase 1

A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors

Completed
NCT01595529Phase 2

The SCOUT Study: "Short Course Therapy for Urinary Tract Infections in Children"

Completed
NCT03752112Phase 1

Trial Evaluating the Clinical Efficacy of Cefixime for Treatment of Early Syphilis in Non-pregnant Women

Unknown
NCT03969758Phase 3

Ciprofloxacin Plus Metronidazole Vs Cefixime Plus Metronidazole Therapy for the Treatment of Liver Abscess

Unknown
NCT01949363Phase 1

The Pharmacokinetics of Extended Duration High-dose Cefixime for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot Study

Completed
NCT02708992Phase 1

Cefixime / Azithromycin pK Study

Completed
NCT01072136Phase 3

Empiric Therapy of Mucopurulent Cervicitis (MPC)

Terminated
NCT00004216Phase 1

VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15